Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 10007
  • Home
  • Print this page
  • Email this page
This article has been cited by
1Bevacizumab tested for treatment of knee osteoarthritis via inhibition of synovial vascular hyperplasia in rabbits
Wei Li,Jianjing Lin,Zhanwei Wang,Shiyou Ren,Xiao Wu,Fei Yu,Jian Weng,Hui Zeng
Journal of Orthopaedic Translation.2019;19()38
[DOI]
2Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration
Ciro Costagliola,Luca Agnifili,Barbara Arcidiacono,Sarah Duse,Vincenzo Fasanella,Rodolfo Mastropasqua,Marco Verolino,Francesco Semeraro
Expert Opinion on Biological Therapy.2012;12(10)1299
[DOI]
3Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration
Thirumurthy Velpandian,Ujjalkumar S. Das
Expert Opinion on Biological Therapy.2016;12(10)385
[DOI]
4Antiproliferative, Apoptotic, and Autophagic Activity of Ranibizumab, Bevacizumab, Pegaptanib, and Aflibercept on Fibroblasts: Implication for Choroidal Neovascularization
Lyubomyr Lytvynchuk,Andrii Sergienko,Galina Lavrenchuk,Goran Petrovski
Journal of Ophthalmology.2015;2015(10)1
[DOI]
5Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma
Vanessa Andrés-Guerrero,Lucía Perucho-González,Julián García-Feijoo,Laura Morales-Fernández,Federico Saenz-Francés,Rocío Herrero-Vanrell,Luis Pablo Júlvez,Vicente Polo Llorens,José María Martínez-de-la-Casa,Anastasios-Georgios P. Konstas
Advances in Therapy.2017;34(2)378
[DOI]
6Real-world data in retinal diseases treated with anti-vascular endothelial growth factor (anti-VEGF) therapy – a systematic approach to identify and characterize data sources
Vincent Daien,Bora M. Eldem,James S. Talks,Jean-Francois Korobelnik,Paul Mitchell,Robert P. Finger,Taiji Sakamoto,Tien Yin Wong,Obaro Evuarherhe,Gemma Carter,Joao Carrasco
BMC Ophthalmology.2019;19(1)378
[DOI]
7Age-Related Macular Degeneration
Sonia Mehta
Primary Care: Clinics in Office Practice.2015;42(3)377
[DOI]
8Clinical Efficacy and Safety of Current Interventions for Choroidal Neovascularization Associated with Rare Diseases: A Systematic Literature Review
Natalie Bennett,Lokho John,Nishkarsh Likhar,Rumjhum Agrawal,Winfried M. Amoaku
Advances in Therapy.2018;35(5)591
[DOI]
9Factors Predicting Treatment Response in Anti-Vascular Endothelial Growth Factor Naïve Diabetic Macular Edema Patients Treated with Intravitreal Bevacizumab
Alastair David Bezzina,Francis Carbonaro
Journal of Ocular Pharmacology and Therapeutics.2019;35(10)551
[DOI]
10Combined therapy in diabetic macular edema
J.H. González-Cortés,J.J. Toledo-Negrete,K. Butrón-Valdez,V. Zapata-Elizondo,B.O. Martínez-Gamero,E.E. Treviño-Cavazos,J.D. Guerra-Leal,J. Mohamed-Hamsho
Medicina Universitaria.2015;17(68)153
[DOI]
11ISCHEMIC CENTRAL RETINAL VEIN OCCLUSION IN THE ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR ERA
Emily K. Tam,Pamela Golchet,Madeline Yung,Francis C. DeCroos,Marc Spirn,Lydia Lehmann-Clarke,Aude Ambresin,Irena Tsui
Retina.2018;38(2)292
[DOI]
12ISCHEMIC CENTRAL RETINAL VEIN OCCLUSION IN THE ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR ERA
Samhitha Gudla,Divya Tenneti,Makrand Pande,Srinivas M. Tipparaju
Retina.2018;38(2)83
[DOI]
13Bevacizumab for eye diseases – Legal, regulatory, and ethical overview
Vinu Jose,Swetha Radhakrishna,Parag Pipalava,Inderjeet Singh
Indian Journal of Pharmacology.2019;51(6)377
[DOI]
14Intrasilicone oil injection of bevacizumab at the end of retinal reattachment surgery for severe proliferative vitreoretinopathy
K Ghasemi Falavarjani,M Hashemi,M Modarres,A Hadavand Khani
Eye.2014;28(5)576
[DOI]
15Subconjunctival Bevacizumab Immediately After Excision of Primary Pterygium: The First Clinical Trial
Abdollah Shenasi,Farideh Mousavi,Solmaz Shoa-Ahari,Babak Rahimi-Ardabili,Rohollah Fadaei Fouladi
Cornea.2011;30(11)1219
[DOI]
16Changing vision: a review of pharmacogenetic studies for treatment response in age-related macular degeneration patients
Janan Arslan,Paul N Baird
Pharmacogenomics.2018;19(5)435
[DOI]
17Effects of a human VEGF antibody (Bevacizumab) on deprivation myopia and choroidal thickness in the chicken
Ute Mathis,Focke Ziemssen,Frank Schaeffel
Experimental Eye Research.2014;127(5)161
[DOI]
18Bevacizumab Induces Upregulation of Keratin 3 and VEGFA in Human Limbal Epithelial Cells in Vitro
Maria Notara,Anna Lentzsch,Thomas Clahsen,Sara Behboudifard,Gabriele Braun,Claus Cursiefen
Journal of Clinical Medicine.2019;8(11)1925
[DOI]
19Bevacizumab for ocular neovascular diseases: a systematic review
Regis Bruni Andriolo,Maria Eduarda Puga,Rubens Belfort Júnior,Álvaro Nagib Atallah
Sao Paulo Medical Journal.2009;127(2)84
[DOI]
20Microspheres as intraocular therapeutic tools in chronic diseases of the optic nerve and retina
Irene Bravo-Osuna,Vanessa Andrés-Guerrero,Alicia Arranz-Romera,Sergio Esteban-Pérez,Irene T. Molina-Martínez,Rocío Herrero-Vanrell
Advanced Drug Delivery Reviews.2018;126(2)127
[DOI]
21Effect of subconjunctival Bevacizumab injection on the outcome of Ahmed glaucoma valve implantation: a randomized control trial
Arezoo Miraftabi,Naveed Nilforushan,Mina Darghahi,Sayyed Amirpooya Alemzadeh,Mohammad Parsamanesh,Maryam Yadgari
Clinical & Experimental Ophthalmology.2018;46(7)750
[DOI]
22Blockade of the VEGF isoforms in inflammatory corneal hemangiogenesis and lymphangiogenesis
Melanie Lipp,Franziska Bucher,Anand Parthasarathy,Deniz Hos,Jasmine Onderka,Claus Cursiefen,Felix Bock
Graefe's Archive for Clinical and Experimental Ophthalmology.2014;252(6)943
[DOI]

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal